Financhill
Back

Xencor 10K Form

Sell
36

XNCR
Xencor

Last Price:
22.21
Seasonality Move:
7.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive XNCR News And Ratings

See the #1 stock for the next 7 days that we like better than XNCR

XNCR Financial Statistics

Sales & Book Value

Annual Sales: $168.34M
Cash Flow: $179.5M
Price / Cash Flow: 21.35
Annual Sales: $10.96
Price / Book: 2.07

Profitability

EPS (TTM): -2.10000
Net Income (TTM): $-126.09M
Gross Margin: $0
Return on Equity: -18.39%
Return on Assets: -15.16%

Xencor Earnings Forecast

Key Xencor Financial Ratios

  • The Gross Profit Margin over the past 4 years for XNCR is 0.00%.
  • The Selling, General & Administrative Expenses for XNCR have been equal to 31.71% of Gross Profit Margin.
  • The Research & Development expenses have been 150.65% of Revenue.
  • The Interest Expense is -0.03% of Operating Income.
  • The Net Earning history of XNCR is -74.90% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

Xencor Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: XNCR
CUSIP: 98401F
Website: xencor.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 7.36
Quick Ratio: 7.14

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

XNCR Technical Analysis vs Fundamental Analysis

Sell
36
Xencor (XNCR) is a Sell

Is Xencor a Buy or a Sell?

  • Xencor stock is rated a Sell
    The current Xencor [XNCR] share price is $22.43. The Score for XNCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.